SCHEMBL136847

SCHEMBL136847

Cc1ccc(C(=O)c2ccsc2N)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.70
KMT2A Q03164 4/20 0.70
RAB9A P51151 2/20 0.70
ALDH1A1 P00352 5/20 0.69
LMNA P02545 3/20 0.69
USP2 O75604 1/20 0.69
GLA P06280 1/20 0.69
HSD17B10 Q99714 1/20 0.69
NPC1 O15118 3/20 0.69
MAPT P10636 5/20 0.58
L3MBTL1 Q9Y468 2/20 0.58
GAA P10253 1/20 0.58
MAPK1 P28482 2/20 0.53
AKR1C3 P42330 1/20 0.47
SRD5A2 P31213 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
HTT P42858 2/20 0.45
CA2 P00918 1/20 0.43
HPGD P15428 2/20 0.43
KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1143297 0.82 MEN1 (0.70) MEN1KMT2ARAB9AALDH1A1LMNA
SCHEMBL5505167 0.82 MEN1 (1.00) MEN1KMT2ARAB9AALDH1A1LMNA
SCHEMBL4065880 0.82 MEN1 (0.70) MEN1KMT2ARAB9AALDH1A1LMNA
SCHEMBL1424722 0.81 ALDH1A1 (1.00) MEN1KMT2ARAB9AALDH1A1LMNA
SCHEMBL8289685 0.81 RAB9A (0.64) MEN1KMT2ARAB9AALDH1A1LMNA
SCHEMBL1365078 0.81 RAB9A (0.72) MEN1KMT2ARAB9AALDH1A1LMNA
SCHEMBL27854840 0.80 MEN1 (0.71) MEN1KMT2ARAB9AALDH1A1LMNA
SCHEMBL12460895 0.79 MEN1 (0.66) MEN1KMT2ARAB9AALDH1A1LMNA
SCHEMBL134249 0.74 MAPT (1.00) MEN1KMT2AALDH1A1LMNAHSD17B10
SCHEMBL2121827 0.73 KMT2A (0.66) MEN1KMT2ARAB9AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2430029-B1 THIENO[2,3-B]PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS UNIV LEUVEN KATH (BE) 2018-01-10 EP disclosed
US-9499563-B2 Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2016-11-22 US disclosed
US-20140296272-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS CISTIM LEUVEN VZW (BE) 2014-10-02 US disclosed
US-8785638-B2 Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2014-07-22 US disclosed
EP-2430029-A1 THIENO [2, 3-B]PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS Katholieke Universiteit Leuven (BE) 2012-03-21 EP disclosed
US-20120059028-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2012-03-08 US disclosed
WO-2010130842-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2010-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296272-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS TYMP, DUT, MAVS MEN1 4548/4885KMT2A 2903/4885RAB9A 2421/4885
US-20120059028-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS TYMP, DUT, MAVS MEN1 4548/4885KMT2A 2903/4885RAB9A 2421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.